Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Germany.
Bioorg Med Chem. 2011 May 15;19(10):3141-51. doi: 10.1016/j.bmc.2011.04.002. Epub 2011 Apr 6.
Various pharmacophore models for potent σ(1) ligands specify a basic amino group flanked by two different hydrophobic regions in defined distances to the basic amine (distance 1 and distance 2, respectively). According to these models distance 1 of the potent spirocyclic σ(1) ligand 1 is too short. In order to find a new class of more potent σ(1) ligands and to verify the distance hypothesis of the pharmacophore models spirocyclic compounds 2 with an exocyclic amino group were designed and synthesized. The secondary amines 8 and 9 with N-benzyl residues are >100-fold less potent than the spirocyclic piperidine 1. However, the tertiary methylamines trans-11 and cis-11 represent potent σ(1) ligands with K(i)-values of 43 and 24 nM, respectively. Whereas one large benzyl moiety is required for high σ(1) receptor binding, a second large N-substituent is not tolerated by the σ(1) receptor protein. As a rule, cis-configured diastereomers with a longer distance 1 (predominantly 7.16-7.23 Å) show higher σ(1) affinities than their trans-configured counterparts (distance 1 is predominantly 5.88-6.26 Å).
各种强效 σ(1)配体的药效团模型规定,碱性氨基基团两侧分别有两个不同的疏水区,与碱性胺的距离分别为距离 1 和距离 2。根据这些模型,强效螺环 σ(1)配体 1 的距离 1 太短。为了找到一类新的更强效的 σ(1)配体,并验证药效团模型的距离假设,设计并合成了具有外环氨基的螺环化合物 2。具有 N-苄基残基的仲胺 8 和 9 的效力比螺环哌啶 1 低 100 倍以上。然而,反式-11 和顺式-11 的叔甲基胺是强效的 σ(1)配体,其 K(i)值分别为 43 和 24 nM。尽管一个大的苄基部分对于高 σ(1)受体结合是必需的,但第二个大的 N-取代基不能被 σ(1)受体蛋白耐受。通常,具有较长距离 1(主要为 7.16-7.23 Å)的顺式构型非对映异构体比其反式构型对应物(距离 1 主要为 5.88-6.26 Å)具有更高的 σ(1)亲和力。